
CureCollect is a precision medicine company specializing in oncology, leveraging AI and diverse multi-modal datasets from the developing world to enhance cancer diagnosis and drug discovery. They provide partner hospitals and labs with free technology upgrades to generate high-quality data including whole slide images, genomics, transcriptomics, and longitudinal EHR with patient outcomes. Their team of data scientists, oncologists, pathologists, and bioinformaticians ensures data quality to support pharmaceutical and biotech collaborations for personalized treatment, biomarker discovery, clinical trial optimization, and AI-driven diagnostic models. CureCollect aims to democratize precision medicine by powering advanced oncology AI with unique datasets from underrepresented populations, improving clinical efficiency and accelerating AI applications in histopathology.

CureCollect is a precision medicine company specializing in oncology, leveraging AI and diverse multi-modal datasets from the developing world to enhance cancer diagnosis and drug discovery. They provide partner hospitals and labs with free technology upgrades to generate high-quality data including whole slide images, genomics, transcriptomics, and longitudinal EHR with patient outcomes. Their team of data scientists, oncologists, pathologists, and bioinformaticians ensures data quality to support pharmaceutical and biotech collaborations for personalized treatment, biomarker discovery, clinical trial optimization, and AI-driven diagnostic models. CureCollect aims to democratize precision medicine by powering advanced oncology AI with unique datasets from underrepresented populations, improving clinical efficiency and accelerating AI applications in histopathology.